Immunization by exposure to live virus (SIV(mne)/HIV-2(287)) during antiretroviral drug prophylaxis may reduce risk of subsequent viral challenge

RATIONALE/STUDY DESIGN: A major challenge in the development of HIV vaccines is finding immunogens that elicit protection against a broad range of viral strains. Immunity to a narrow range of viral strains may protect infants of HIV-infected women or partners discordant for HIV. We hypothesized that...

Descripción completa

Detalles Bibliográficos
Autores principales: Frenkel, Lisa M., Kuller, LaRene, Beck, Ingrid A., Tsai, Che-Chung, Joy, Jaimy P., Mulvania, Thera M., Hu, Shiu-Lok, Montefiori, David C., Anderson, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084236/
https://www.ncbi.nlm.nih.gov/pubmed/33914754
http://dx.doi.org/10.1371/journal.pone.0240495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084236/
https://www.ncbi.nlm.nih.gov/pubmed/33914754
http://dx.doi.org/10.1371/journal.pone.0240495

Ejemplares similares